MarketInOut Stock Screener Log In | Sign Up

Drugs Made In America Acquisition II Corp

NASDAQ • Financial Services • Shell Companies • Quote as of 10/26/2026
Drugs Made In America Acquisition II Corp stock price and volume chart

Company Profile

IndustryShell Companies
SectorFinancial Services
ExchangeNASDAQ
Market Capitalization649.1 mln
Float49.59 mln
Earnings Date11/18/2026

EPS

0.30
Overpriced

P / E

33.98
Overvalued

Relative Strength

64 / 100
Outperforming

Debt / Equity

0.00
Debt-free

ROE

3.33
Very low

ROA

3.21
Low

Business Description

Founded in 2024 and headquartered in Fort Lauderdale, Florida, this company was established for the purpose of identifying and acquiring an existing business through a merger, asset purchase, or similar transaction. It currently has no active operations of its own.

Key Fundamentals

EPS0.30
P/E33.98
ROE3.33
ROIC-0.36
ROA3.21
EBITDA, mln13.02
EV / EBITDA49.83
EV / EBIT49.83

Quote Details

Last 10.20
Change 0.01 (0.1%)
Open 10.19
Volume 188,029
Turnover 1,917,896
Average Volume 236,334

Financial Ratios

Leverage Ratio1.04
Current Ratio0.34
Price / Book1.31
Price / Tangible Book1.31
Debt / Equity0.00

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.2% 57 / 100   
1 Month 0.49% 71 / 100   
2 Months 0.99% 67 / 100   
6 Months 2.1% 61 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog